000			02171 a2200613 4500
005			20250514000918.0
264		0	_c19970106
008			199701s 0 0 eng d
022			_a1523-2883
040			_aNLM _beng _cNLM
100	1		_aGrodeck, B
245	0	0	_aThe kissing question and other ICAAC highlights. _h[electronic resource]
260			_bPositively aware : the monthly journal of the Test Positive Aware Network _c
300			_a33-4, 39 p. _bdigital
500			_aPublication Type: Congress; Newspaper Article
650	0	4	_aAIDS-Related Opportunistic Infections _xcomplications
650	0	4	_aAdult
650	0	4	_aAnti-Bacterial Agents
650	0	4	_aAntiviral Agents _xtherapeutic use
650	0	4	_aBisexuality
650	0	4	_aCD4 Lymphocyte Count _xdrug effects
650	0	4	_aChild
650	0	4	_aCytomegalovirus Retinitis
650	0	4	_aDidanosine _xtherapeutic use
650	0	4	_aDisease Progression
650	0	4	_aDisease Transmission, Infectious _xprevention & control
650	0	4	_aDrug Interactions
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFluconazole _xtherapeutic use
650	0	4	_aHIV Infections _xcomplications
650	0	4	_aHIV Protease Inhibitors _xadverse effects
650	0	4	_aHand Disinfection
650	0	4	_aHerpesvirus 8, Human
650	0	4	_aHomosexuality, Male
650	0	4	_aHumans
650	0	4	_aIndinavir _xadverse effects
650	0	4	_aInterleukin-2 _xadverse effects
650	0	4	_aLamivudine _xtherapeutic use
650	0	4	_aMale
650	0	4	_aMedication Errors
650	0	4	_aMicrosporidiosis
650	0	4	_aMycobacterium avium-intracellulare Infection
650	0	4	_aNational Institutes of Health (U.S.)
650	0	4	_aPharmacists
650	0	4	_aPneumonia, Pneumocystis
650	0	4	_aSaliva _xvirology
650	0	4	_aSarcoma, Kaposi
650	0	4	_aTrimethoprim, Sulfamethoxazole Drug Combination _xadverse effects
650	0	4	_aUnited States
650	0	4	_aViral Load
650	0	4	_aZalcitabine _xtherapeutic use
650	0	4	_aZidovudine _xtherapeutic use
773	0		_tPositively aware : the monthly journal of the Test Positive Aware Network _gvol. 7 _gno. 6 _gp. 33-4, 39
999			_c11295987 _d11295987